Literature DB >> 33061145

Outcome of surgery for acute infective endocarditis: does preoperative stroke have an impact on mortality?

Nadejda Monsefi1, Mahmut Öztürk1, Tunjay Shavahatli1, Ali Ahmad El-Sayed1, Farhad Bakhtiary1.   

Abstract

PURPOSE: Surgical therapy of infective endocarditis (IE) is challenging and can be associated with high mortality. In this study, we present the early outcomes of patients who underwent cardiac surgery for IE.
METHODS: From 2017 until 2019, 66 patients underwent surgical treatment for IE. Staphylococcus aureus infection was identified in 14 patients (21%). In the same period, about 813 valve replacement procedures were performed with 8% incidence of IE. Mean age was 66 ± 12 years and 32% were females. Mean ejection fraction was 55 ± 9%. Seven patients (11%) had stroke due to septic embolism preoperatively. In 20 patients (30%), prosthetic valve endocarditis was an indication for reoperation. Thirty-day postoperative mortality and impact of preoperative stroke were analyzed.
RESULTS: Thirty-day mortality was 17% (n = 11). Mean EuroSCORE I was 28 ± 22%. Mean cross clamp time was 63 ± 37 min. Fourty patients (61%) underwent one-valve procedure, 25 patients (38%) had double-valve, and one (1%) triple-valve operation. All seven patients with preoperative neurologic dysfunction had unremarkable postoperative course without death or neurologic deterioration. Five of them had no worsening in neurological status, while 2 patients had slight improvement in speech. The comparison between the two groups (patients without preoperative neurological vs. patients with preoperative neurological dysfunction) revealed no significance in the postoperative mortality rate (18% vs. 0% with p = 0.26). Postoperative echocardiography revealed competent valve function in all cases.
CONCLUSION: Surgical treatment for IE still remains a challenge with high morbidity and mortality. Patients with preoperative neurologic dysfunction due to septic embolism have good early postoperative results without increased mortality. © Indian Association of Cardiovascular-Thoracic Surgeons 2020.

Entities:  

Keywords:  Infective endocarditis; Minimally invasive; Mitral valve replacement; Stroke

Year:  2020        PMID: 33061145      PMCID: PMC7525743          DOI: 10.1007/s12055-020-00943-y

Source DB:  PubMed          Journal:  Indian J Thorac Cardiovasc Surg        ISSN: 0970-9134


  16 in total

1.  A risk factor analysis for in-hospital mortality after surgery for infective endocarditis and a proposal of a new predictive scoring system.

Authors:  Giuseppe Gatti; Bernardo Benussi; Florida Gripshi; Alessio Della Mattia; Alberto Proclemer; Antonio Cannatà; Lorella Dreas; Roberto Luzzati; Gianfranco Sinagra; Aniello Pappalardo
Journal:  Infection       Date:  2017-01-04       Impact factor: 3.553

Review 2.  Is there any difference between blood and crystalloid cardioplegia for myocardial protection during cardiac surgery? A meta-analysis of 5576 patients from 36 randomized trials.

Authors:  M P B O Sá; F G Rueda; P E Ferraz; S T Chalegre; F P Vasconcelos; R C Lima
Journal:  Perfusion       Date:  2012-07-31       Impact factor: 1.972

3.  Myocardial protection.

Authors:  H J Bretschneider
Journal:  Thorac Cardiovasc Surg       Date:  1980-10       Impact factor: 1.827

4.  Surgical treatment for active infective prosthetic valve endocarditis: 22-year single-centre experience.

Authors:  Michele Musci; Michael Hübler; Aref Amiri; Julia Stein; Susanne Kosky; Rudolf Meyer; Yuguo Weng; Roland Hetzer
Journal:  Eur J Cardiothorac Surg       Date:  2010-05-23       Impact factor: 4.191

Review 5.  Challenges in Infective Endocarditis.

Authors:  Thomas J Cahill; Larry M Baddour; Gilbert Habib; Bruno Hoen; Erwan Salaun; Gosta B Pettersson; Hans Joachim Schäfers; Bernard D Prendergast
Journal:  J Am Coll Cardiol       Date:  2017-01-24       Impact factor: 24.094

6.  Infective endocarditis: mid-term prognosis in patients with good in-hospital outcome.

Authors:  José Zamorano; Leopoldo Pérez de Isla; Gracieta Malangatana; Carlos Almería; José Luis Rodrigo; Adalia Aubele; Isidre Vilacosta; Enrique Rodriguez; Carlos Macaya
Journal:  J Heart Valve Dis       Date:  2005-05

7.  Long-term Outcomes of Surgery for Invasive Valvular Endocarditis Involving the Aortomitral Fibrosa.

Authors:  José L Navia; Haytham Elgharably; Ali H Hakim; James C Witten; Michael J Haupt; Emidio Germano; Penny L Houghtaling; Faisal G Bakaeen; Gösta B Pettersson; Bruce W Lytle; Eric E Roselli; A Marc Gillinov; Lars G Svensson
Journal:  Ann Thorac Surg       Date:  2019-06-27       Impact factor: 4.330

8.  Association between surgical indications, operative risk, and clinical outcome in infective endocarditis: a prospective study from the International Collaboration on Endocarditis.

Authors:  Vivian H Chu; Lawrence P Park; Eugene Athan; Francois Delahaye; Tomas Freiberger; Cristiane Lamas; Jose M Miro; Daniel W Mudrick; Jacob Strahilevitz; Christophe Tribouilloy; Emanuele Durante-Mangoni; Juan M Pericas; Nuria Fernández-Hidalgo; Francisco Nacinovich; Hussien Rizk; Vladimir Krajinovic; Efthymia Giannitsioti; John P Hurley; Margaret M Hannan; Andrew Wang
Journal:  Circulation       Date:  2014-12-05       Impact factor: 29.690

9.  Results of surgical management of infective endocarditis associated with Staphylococcus aureus.

Authors:  Kota Suzuki; Daisuke Yoshioka; Koichi Toda; Jun-Ya Yokoyama; Takaaki Samura; Shigeru Miyagawa; Yasushi Yoshikawa; Hiroki Hata; Hiroshi Takano; Goro Matsumiya; Taichi Sakaguchi; Hirotsugu Fukuda; Yoshiki Sawa
Journal:  Eur J Cardiothorac Surg       Date:  2019-07-01       Impact factor: 4.191

10.  Mortality Predictors in the Surgical Treatment of Active Infective Endocarditis.

Authors:  Jenny Lourdes Rivas de Oliveira; Magaly Arrais Dos Santos; Renato Tambellini Arnoni; Auristela Ramos; Dorival Della Togna; Samira Kaissar Ghorayeb; Roberto Tadeu Magro Kroll; Luiz Carlos Bento de Souza
Journal:  Braz J Cardiovasc Surg       Date:  2018 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.